Overview


According to FutureWise analysis the market for Periodontal Therapeutics in 2023 is US$ 0.77 billion, and is expected to reach US$ 1.57 billion by 2031 at a CAGR of 9.40%.

Periodontal therapy is a non-surgical, conservative treatment for gum disease. Its goal is to prevent and treat periodontal diseases without the use of surgery. Finally, it aids in the restoration of optimal gum health, which aids in the prevention of tooth loss. Gingivitis can also be helped by periodontal therapy. Gingivitis is not the same as periodontitis because it is only an inflammation of the gums. Untreated gingivitis, on the other hand, can progress to periodontal disease. Periodontal therapy was also found to be effective for moderate chronic periodontitis, according to the researchers.

Periodontal disorders, often known as periodontitis, are degenerative conditions brought on by infections and inflammation of the periodontium, the tissue that surrounds and supports the teeth. This disease is brought on and maintained in susceptible hosts by pathogenic bacteria that live in intricate biofilms. Broad-spectrum antibiotic therapy has occasionally been a preferred method of bacterial infection control. Unfortunately, treating periodontal diseases has become significantly more difficult due to rising antibiotic resistance among periodontal microorganisms. The main objective of periodontal therapy has changed in recent years to the restoration of homeostasis in the oral microbiota and its harmonious balance with the host periodontal tissues as a result of advances in the understanding of the pathogenesis of the periodontal disease, which involves the host immune response, and the significance of the human microbiome. Alternative methods to antibiotic therapy that indiscriminately eradicate both harmful and helpful microorganisms are necessary, given the shift in therapeutic goals and the problem of drug resistance.

FutureWise Market Research has published a report that provides an insightful analysis of periodontal therapeutics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the periodontal therapeutics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • 3M Company
  • Den-Mat Holdings, LLC
  • Dexcel Pharma
  • Kaken Pharmaceutical Co., Ltd.
  • Oral Science
  • Valeant Pharmaceuticals International, Inc.
  • Tolmar Pharmaceuticals
  • Eli Lilly and Company
  • Align Technology, Inc.
  • Glidewell Laboratories
  • Orapharma
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma L.P.
  • Nobel Biocare Holdings AG
  • Ultradent Products Inc.
  • Fibrocell Sciences, Inc
  • Dentsply International

(Note: The list of the major players will be updated with the latest market scenario and trends)

Periodontal diseases range from minor gum irritation to severe conditions that can seriously harm the bone and soft tissues that support the teeth. Oral hygiene is one of the most important aspects of overall health. Thus, increasing consumer awareness of oral hygiene, particularly in developed countries, is expected to support market growth. Furthermore, changing eating habits, rising oral health awareness, a geriatric population, and an increase in patients with periodontal problems are major drivers driving revenue growth in the market. Factors such as smoking, diabetes, stress, and poor oral hygiene can all increase the risk of developing periodontal disease. As a result, rising lifestyle modifications and diabetes cases are propelling the periodontal therapeutics market during the forecast period. Due to a lack of personal hygiene awareness, the market for periodontal treatments is experiencing difficulties in emerging countries. Lack of awareness of the symptoms connected to periodontal diseases would probably cause the diagnosis and treatment to be delayed. Because of the prevalence of periodontal diseases, several leading market players have increased their research and development efforts in the field. The development of new advanced periodontal therapeutics is expected to increase periodontal disease therapeutic adoption. Several manufacturers are currently developing products. Some companies have already started clinical trials for periodontal therapeutics, which are expected to meet demand and open up new opportunities in the target market.

By Product Type

  • Systemic Antibiotics
    •   Doxycycline
    •   Minocycline
    •   Metronidazole
    •   Others
  • Local Antibiotics
    •   Arestin
    •   Periochip
    •   Atridox
    •   Others

By Type

  • Gingivitis
  • Chronic Periodontitis
  • Aggressive Periodontitis
  • Necrotizing Periodontal

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-Commerce 

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. It is mostly attributed to the rising number of diabetics, geriatrics, and patients with periodontal illnesses in the region. The rise in healthcare spending, sophisticated healthcare infrastructure, high level of drug development, well-established market players, high investment in R&D activities by key players, and an appropriate regulatory framework for periodontal drugs are additional factors that are increasing the regional market share. For instance, the ADA Science & Research Institute at the University of Pennsylvania received a $2 million grant from the NIH in August 2021 to examine oral mucosa. In order to better understand how periodontal disease and peri-implantitis affect the oral epithelium's ability to act as a barrier, the American Dental Association Science & Research Institute will collaborate with the University of Pennsylvania School of Dental Medicine. Also, by type, gingivitis holds the highest market share in the global market in 2022.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Periodontal Therapeutics Market By Product Type, By Type, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to:sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Periodontal Therapeutics Market Variables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Periodontal Therapeutics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Periodontal Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Periodontal Therapeutics Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Systemic Antibiotics
         1.1. Doxycycline
         1.2. Minocycline
         1.3. Metronidazole
         1.4. Others
        2. Local Antibiotics
         2.1. Arestin
         2.2. Periochip
         2.3. Atridox
         2.4. Others

  • 8.   Periodontal Therapeutics Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Gingivitis
        2. Chronic Periodontitis
        3. Aggressive Periodontitis
        4. Necrotizing Periodontal

  • 9.   Periodontal Therapeutics Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Drug Stores
        4. E-Commerce

  • 10.   North America Periodontal Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Periodontal Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Periodontal Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Periodontal Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Periodontal Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. 3M Company
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Den-Mat Holdings, LLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Dexcel Pharma
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Kaken Pharmaceutical Co., Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Oral Science
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Valeant Pharmaceuticals International, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Tolmar Pharmaceuticals
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Eli Lilly and Company
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Align Technology, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Glidewell Laboratories
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Orapharma
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Mallinckrodt Pharmaceuticals
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Purdue Pharma L.P
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Nobel Biocare Holdings AG
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Ultradent Products Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Fibrocell Sciences, Inc
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Dentsply International
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients